Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Adherens junction 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
2 Adherens junction 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
3 Adherens junction 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
4 Adherens junction 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
5 AMPK signaling pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
6 AMPK signaling pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
7 AMPK signaling pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
8 AMPK signaling pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
9 Autophagy - animal 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
10 Autophagy - animal 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
11 Autophagy - animal 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
12 Autophagy - animal 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
13 Breast cancer 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
14 Breast cancer 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
15 Breast cancer 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
16 Breast cancer 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
17 Cadherin signaling 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
18 Cadherin signaling 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
19 Cadherin signaling 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
20 Cadherin signaling 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
21 Endocytosis 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
22 Endocytosis 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
23 Endocytosis 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
24 Endocytosis 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
25 Focal adhesion 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
26 Focal adhesion 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
27 Focal adhesion 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
28 Focal adhesion 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
29 FoxO signaling pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
30 FoxO signaling pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
31 FoxO signaling pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
32 FoxO signaling pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
33 Glioma 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
34 Glioma 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
35 Glioma 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
36 Glioma 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
37 Hepatocellular carcinoma 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
38 Hepatocellular carcinoma 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
39 Hepatocellular carcinoma 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
40 Hepatocellular carcinoma 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
41 HIF-1 signaling pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
42 HIF-1 signaling pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
43 HIF-1 signaling pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
44 HIF-1 signaling pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
45 Hormone signaling 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
46 Hormone signaling 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
47 Hormone signaling 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
48 Hormone signaling 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
49 Integrin signaling 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
50 Integrin signaling 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
51 Integrin signaling 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
52 Integrin signaling 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
53 Long-term depression 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
54 Long-term depression 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
55 Long-term depression 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
56 Long-term depression 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
57 Longevity regulating pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
58 Longevity regulating pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
59 Longevity regulating pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
60 Longevity regulating pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
61 Longevity regulating pathway - multiple species 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
62 Longevity regulating pathway - multiple species 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
63 Longevity regulating pathway - multiple species 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
64 Longevity regulating pathway - multiple species 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
65 MAPK signaling pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
66 MAPK signaling pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
67 MAPK signaling pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
68 MAPK signaling pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
69 Melanoma 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
70 Melanoma 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
71 Melanoma 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
72 Melanoma 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
73 mTOR signaling pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
74 mTOR signaling pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
75 mTOR signaling pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
76 mTOR signaling pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
77 Oocyte meiosis 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
78 Oocyte meiosis 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
79 Oocyte meiosis 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
80 Oocyte meiosis 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
81 Ovarian steroidogenesis 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
82 Ovarian steroidogenesis 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
83 Ovarian steroidogenesis 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
84 Ovarian steroidogenesis 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
85 Pathways in cancer 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
86 Pathways in cancer 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
87 Pathways in cancer 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
88 Pathways in cancer 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
89 PI3K-Akt signaling pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
90 PI3K-Akt signaling pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
91 PI3K-Akt signaling pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
92 PI3K-Akt signaling pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
93 Progesterone-mediated oocyte maturation 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
94 Progesterone-mediated oocyte maturation 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
95 Progesterone-mediated oocyte maturation 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
96 Progesterone-mediated oocyte maturation 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
97 Prostate cancer 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
98 Prostate cancer 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
99 Prostate cancer 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
100 Prostate cancer 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
101 Proteoglycans in cancer 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
102 Proteoglycans in cancer 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
103 Proteoglycans in cancer 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
104 Proteoglycans in cancer 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
105 Rap1 signaling pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
106 Rap1 signaling pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
107 Rap1 signaling pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
108 Rap1 signaling pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
109 Ras signaling pathway 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
110 Ras signaling pathway 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
111 Ras signaling pathway 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
112 Ras signaling pathway 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
113 Signaling pathways regulating pluripotency of stem cells 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
114 Signaling pathways regulating pluripotency of stem cells 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
115 Signaling pathways regulating pluripotency of stem cells 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
116 Signaling pathways regulating pluripotency of stem cells 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬
117 Transcriptional misregulation in cancer 💬
[1] IGF1R 💬 Linsitinib 💬 Linsitinib [1] 232 💬
118 Transcriptional misregulation in cancer 💬
[1] IGF1R 💬 Mecasermin 💬 Mecasermin [4] 96, 168, 265, 299 💬
119 Transcriptional misregulation in cancer 💬
[1] IGF1R 💬 Mecasermin rinfabate 💬 Mecasermin [4] 96, 168, 265, 299 💬
120 Transcriptional misregulation in cancer 💬
[1] IGF1R 💬 Teprotumumab 💬 Teprotumumab [1] 49 💬